AG
SRGA

Aperio Group’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Aperio Group’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-60
Closed -$8K – 2907
2019
Q2 		$8K Buy
+60
New +$8.64K ﹤0.01% 2815

Other funds holding SRGA

PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aperio Group's SRGA Position: Q3 2019 in Review

Aperio Group sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2019, closing a stake of 60 shares — an estimated $8K sold.

Aperio Group first reported a position in SRGA in Q2 2019 and held it in 1 quarter. The position peaked at $8K in Q2 2019. 97 funds tracked by Wall St. Rank hold SRGA as of Q3 2019.

  • Aperio Group reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Aperio Group sold 60 Surgalign Holdings, Inc. Common Stock shares in Q3 2019, an estimated $8K.
  • Aperio Group first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Aperio Group's Surgalign Holdings, Inc. Common Stock position peaked at $8K in Q2 2019.
  • 97 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2019.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.